Improved remission rates acquired by adding adalimumab to methotrexate and intraarticular glucocorticoid cannot be maintained after withdrawal of adalimumab: A 2-year investigator initiated randomised, controlled study on early rheumatod arthritis

Kim Hørslev-Petersen, ML Hetland, Peter Junker, J Pødenphant, Torkell Juulsgaad Ellingsen, P Ahlqvist, Hanne Merete Lindegaard, Asta Linauskas, Annette Schlemmer, MY Dam, I Hansen, Tine Lottenburger, A Jørgensen, SB Krintel, J Raun, Christian Gytz Ammitzbøll, JS Johansen, M Østergaard, Kristian Stengaard-Pedersen

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato2013
StatusUdgivet - 2013
BegivenhedEULAR 2013 Madrid: European Congress of Rheumatology - Madrid, Spanien
Varighed: 12. jun. 201315. jun. 2013

Konference

KonferenceEULAR 2013 Madrid
LandSpanien
ByMadrid
Periode12/06/201315/06/2013

Citationsformater